임상시험

Strategy TO Prevent Decompensated Heart Failure

NCT: NCT06641921 · COMPLETED

NCT IDNCT06641921

상태COMPLETED

시작일2024-05-01

완료2026-05-01

SponsorSeerlinq s. r. o. (OTHER)

First posted2024-10-15

Last updated2026-10-07

간략 요약

The goal of this prospective, multicenter, single-arm, open-label clinical trial (Strategy TO Prevent Decompensated Heart Failure) is to evaluate the 12-month incidence of heart failure hospitalization (HFH) and all cause mortality in patients managed with haemodynamically guided treatment using the Seerlinq telemedical monitoring system.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.